Company: APM
Filing Date: 2025-10-14
Form Type: 424B5
Source: 0001213900-25-098635
Chunk: 60

Company: Aptorum Group Ltd
Filing Date: 2025-10-14
Form: 424B5
Chunk 60
---
 book value of their shares.

The price per Class A Ordinary
Share being offered may be higher than the net tangible book value per share of our outstanding Class A Ordinary Shares prior to this
offering. An aggregate of 1,000,000 Class A Ordinary Shares are sold at a price of $2.00 per share are sold, for aggregate gross proceeds
of $2.00, and after deducting commissions and estimated offering expenses payable by us, as a result of this offering, the existing shareholders
will incur immediate dilution of $0.15 per Ordinary Share, representing the difference between the assumed offering price and our as adjusted
net tangible book value as of June 30, 2025. For a more detailed discussion of the foregoing, see the section entitled “Dilution”
on page S-36. To the extent outstanding stock options are exercised, there may be further dilution to new investors.

You may experience future dilution as a result of future equity offerings.

In order to raise additional
capital, we may in the future offer additional Class A Ordinary Shares or other securities convertible into or exchangeable for our Class
A Ordinary Shares at prices that may not be the same as the price per share in this offering. The price per share at which we sell additional
Class A Ordinary Shares, or securities convertible or exchangeable into Class A Ordinary Shares, in future transactions may be lower than
the price per share paid by investors in this offering.

A substantial number of Class A Ordinary Shares may be sold in the market following this offering, which may depress the market price for our Class A Ordinary Shares.

Sales of a substantial
number of Class A Ordinary Shares in the public market following this offering could cause the market price of our Class A Ordinary Shares
to decline. A substantial majority of the outstanding Class A Ordinary Shares are, and the Class A Ordinary Shares sold in this offering
upon issuance will be, freely tradable without restriction or further registration under the Securities Act.

Securities analysts may not cover our ordinary shares, and this may have a negative impact on the market price of our ordinary shares.

The trading market for our ordinary shares will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over independent analysts (provided that we have engaged various non-independent analysts). We do not currently have and may never obtain research coverage by independent securities and industry analysts. If no independent securities or industry analysts commence coverage of us, the trading